These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26243205)

  • 21. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
    Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
    Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of targeted therapies in the treatment of triple-negative breast cancer.
    Jia LY; Shanmugam MK; Sethi G; Bishayee A
    Anticancer Drugs; 2016 Mar; 27(3):147-55. PubMed ID: 26682525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution.
    Hollenberg SM
    Crit Care Med; 1998 May; 26(5):815-6. PubMed ID: 9590305
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of nitric oxide synthase has an analgesic effect in chronic pain].
    Ashina M; Lassen LH; Bendtsen L; Jensen RA; Olesen J
    Ugeskr Laeger; 2000 Jan; 162(2):171-3. PubMed ID: 10647315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Janus faces of NO?
    Gödecke A; Schrader J
    Circ Res; 2004 Apr; 94(6):e55. PubMed ID: 14764455
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selective oral aromatase suppression and thymidilate synthase inhibition].
    Chirurg; 1997 Feb; 68(2 Suppl):1-16. PubMed ID: 9131060
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence of a role for endothelium-derived nitric oxide in the regulation of vascular tone during acute haemorrhage.
    Mellander S; Ekelund U
    Acta Physiol Scand; 1995 Jul; 154(3):419-20. PubMed ID: 7572240
    [No Abstract]   [Full Text] [Related]  

  • 29. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
    Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
    Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization.
    Lee KS; Lee DK; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2012 Feb; 418(1):49-55. PubMed ID: 22240022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
    López AS; Alegre E; Díaz A; Mugueta C; González A
    Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of nitric oxide in the pathogenesis and therapy of hemorrhagic shock].
    Todorović Z; Prostran M; Zunić G; Varagić VM; Savić J
    Vojnosanit Pregl; 1997; 54(2):133-8. PubMed ID: 9265378
    [No Abstract]   [Full Text] [Related]  

  • 33. Thymidylate synthase inhibitors.
    Takimoto CH; Diggikar S
    Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
    [No Abstract]   [Full Text] [Related]  

  • 34. Nitric oxide enhances collagen synthesis in cultured human tendon cells.
    Xia W; Szomor Z; Wang Y; Murrell GA
    J Orthop Res; 2006 Feb; 24(2):159-72. PubMed ID: 16435353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathways: PI3K pathway targets in triple-negative breast cancers.
    Gordon V; Banerji S
    Clin Cancer Res; 2013 Jul; 19(14):3738-44. PubMed ID: 23748695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presurgery treatment combo more effective for women with triple-negative breast cancer.
    R I Med J (2013); 2014 Jan; 97(1):59. PubMed ID: 24960873
    [No Abstract]   [Full Text] [Related]  

  • 38. Intracerebroventricular injection of neuronal and inducible nitric oxide synthase inhibitors attenuates fever due to LPS in rats.
    Soszynski D; Chelminiak M
    J Physiol Pharmacol; 2007 Sep; 58(3):551-61. PubMed ID: 17928650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
    von Minckwitz G; Schneeweiss A; Loibl S; Salat C; Denkert C; Rezai M; Blohmer JU; Jackisch C; Paepke S; Gerber B; Zahm DM; Kümmel S; Eidtmann H; Klare P; Huober J; Costa S; Tesch H; Hanusch C; Hilfrich J; Khandan F; Fasching PA; Sinn BV; Engels K; Mehta K; Nekljudova V; Untch M
    Lancet Oncol; 2014 Jun; 15(7):747-56. PubMed ID: 24794243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?
    Jacot W; Theillet C; Guiu S; Lamy PJ
    Future Oncol; 2015; 11(4):557-9. PubMed ID: 25686112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.